ProShare Advisors LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$90,000
-39.6%
11,849
-19.1%
0.00%
Q4 2021$149,000
-21.2%
14,647
+4.1%
0.00%
-100.0%
Q3 2021$189,000
-51.4%
14,070
-20.6%
0.00%0.0%
Q2 2021$389,000
+8.4%
17,730
+18.9%
0.00%0.0%
Q1 2021$359,000
+48.3%
14,910
+11.1%
0.00%0.0%
Q4 2020$242,000
+103.4%
13,425
+30.2%
0.00%0.0%
Q3 2020$119,000
-54.1%
10,309
-3.4%
0.00%0.0%
Q2 2020$259,000
-22.9%
10,668
-16.1%
0.00%
-50.0%
Q4 2019$336,000
+5.3%
12,714
-9.3%
0.00%0.0%
Q3 2019$319,000
-22.4%
14,011
+4.6%
0.00%0.0%
Q2 2019$411,000
+62.5%
13,391
-12.1%
0.00%0.0%
Q1 2019$253,000
-11.8%
15,231
+1.5%
0.00%0.0%
Q4 2018$287,000
-66.1%
15,003
-7.2%
0.00%
-66.7%
Q3 2018$846,000
+18.5%
16,171
-1.6%
0.01%
+20.0%
Q2 2018$714,000
+29.6%
16,431
+10.4%
0.01%
+25.0%
Q1 2018$551,000
+69.0%
14,877
-9.5%
0.00%
+100.0%
Q4 2017$326,00016,4380.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders